Syndromic real-time PCR tests for respiratory infections provide economic advantages by improving healthcare utilization and ...

Panelists discuss how accurate and early diagnosis remains one of the most difficult challenges in schizophrenia care. Many ...

Panelists discuss how genetic predisposition is a major determinant in schizophrenia risk, with heritability playing a ...

Panelists discuss how pharmacy-driven barriers, including delayed statin initiation and failure to escalate therapy, ...

Medicare Advantage plans that place greater restrictions on home health agency care delivery may have more adverse patient outcomes than plans that provide episodic payments.

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 receptor agonists, aligning with the Most Favored Nation executive ...

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for ...

A new option is now approved to treat adults living with high-risk smoldering multiple myeloma. 1 The FDA has greenlit ...

Explore how the WISeR Model addresses prior authorization reform, Medicare costs, and AI's role in tackling the health care ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

In late September, oncology experts gathered in Nashville, Tennessee, for the 2025 Patient-Centered Oncology Care ® conference. Over 2 days, 15 panel discussions explored topics aligned with this year ...